- LivaNova Reports First-Quarter 2024 Results
- LivaNova Announces Ahmet Tezel, Ph.D., as Chief Innovation Officer
- LivaNova Issues Notice to U.S. Patients Regarding Cybersecurity Incident
- LivaNova to Announce First-Quarter 2024 Results
- LivaNova Announces a Positive Predictive Outcome of Trial Success in its OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea
- LivaNova Announces Pricing of Private Offering of $300 Million of 2.50% Convertible Senior Notes Due 2029
- LivaNova to Present at the Barclays Global Healthcare Conference
- LivaNova Reports Fourth-Quarter and Full-Year 2023 Results
More ▼
Key statistics
On Wednesday, LivaNova PLC (LIVN:NSQ) closed at 63.20, -1.98% below its 52-week high of 64.48, set on May 06, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 61.48 |
---|---|
High | 63.52 |
Low | 61.48 |
Bid | 62.75 |
Offer | 64.55 |
Previous close | 61.43 |
Average volume | 632.05k |
---|---|
Shares outstanding | 54.15m |
Free float | 53.98m |
P/E (TTM) | -- |
Market cap | 3.33bn USD |
EPS (TTM) | -0.5911 USD |
Data delayed at least 15 minutes, as of May 15 2024 21:00 BST.
More ▼